
Sign up to save your podcasts
Or
Are you up to date on the new developments for emerging therapies for your patients with transthyretin amyloid cardiomyopathy (ATTR-CM)?
Credit available for this activity expires: 12/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002007?ecd=bdc_podcast_libsyn_mscpedu
4.2
2222 ratings
Are you up to date on the new developments for emerging therapies for your patients with transthyretin amyloid cardiomyopathy (ATTR-CM)?
Credit available for this activity expires: 12/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002007?ecd=bdc_podcast_libsyn_mscpedu
126 Listeners
38 Listeners
13 Listeners
319 Listeners
854 Listeners
479 Listeners
689 Listeners
16 Listeners
275 Listeners
251 Listeners
3,318 Listeners
91 Listeners
1,086 Listeners
175 Listeners
514 Listeners
318 Listeners
58 Listeners
8 Listeners
245 Listeners
365 Listeners